Tag: HR+ positive
Trodelvy for Secondary Breast Cancer: Science and Stories
Sacituzumab govitecan (Trodelvy®) is used to treat certain secondary breast cancers. This blog delves into the science while looking at the real experiences of patient’s on this drug.
Tumour gene tests: What are they and why should you know about them?
Genomic tests have changed how cancer is treated. In this blog we explain the objective and the different types of genomic tests available.
Living with HR+ Secondary Breast Cancer: Jacqui Crewe’s Story
In this blog we want to share with you the experience from Jacqui Crewe, a secondary patient with HR+, HER- breast cancer.